Strong Start to Fiscal Year 2025
Enovis Corporation reported an 8% growth in Q1 2025 and an 11% growth on a comparable basis. Adjusted EBITDA margins expanded by 160 basis points.
Recon Segment Growth
The Recon segment delivered a comparable growth of 13%, with U.S. Recon growing 11% and international markets growing 14%.
Adjustments in Financial Guidance
Revenue guidance for 2025 increased by $30 million, reflecting positive currency adjustments. Expected revenue range is now $2.22 billion to $2.25 billion.
Adjusted EBITDA and EPS Growth
Adjusted EBITDA grew 19% year-over-year, with adjusted earnings per share increasing by 62% to $0.81.
New Product Launches and Innovations
Successful product launches, including the augmented reverse glenoid system, nebula stem, and ARVIS technology, are driving growth and market expansion.